Rachel Willand-Charnley (@RAWC_Lab) header
Rachel Willand-Charnley (@RAWC_Lab) profile picture

Applied Organic Chemist| Glyco-Cancer Immunologist| Co-author-Lessons Learned|Assoc Prof|Views expressed are my own.

Joined May 2023
I can’t wait for the next event that brings us all together. Until next time Bertozzi family! @Stanford_ChEMH
3
37
4,072
Had another wonderful opportunity to share in my experience with the next generation of PIs through the Younger Chemist Committee, @AmerChemSociety.
5
394
It has been an incredible few weeks. Recently, I participated as a panelist (The Tenure Track: A Guide for Underrepresented Scholars) during the Women in Leadership conference that took place at Harvard University along side Drs. Ann Hilliard and Danielle Holley.
5
309
Engaging in intellectual discourse with President Willie-LeBreton, during our Women in Leadership conference, was fantastic, thank you Sarah. @NatDC @Harvard
1
215
Had the wonderful opportunity to congratulate @raflynn5 on his lab’s recent publication. It is always good to catch up with a fellow Bertozzian!
1
414
I am ready to inspire and guide as a panelist, but I am here to listen and be inspired by a collective of amazing women during the Women in Leadership conference. @Harvard @faculty_club
1
182
Congratulations to the newly minted Dr. Das, the fourth PhD from @RAWC_Lab. I am confident you will continue to make substantive contributions during your postdoc at the @ClevelandClinic with the Bin Zhang lab, and in the years to come, I can’t wait. #glycotime
4
230
Congratulations to Dr. Tuffour who successfully defended! You will find him as a Senior Scientist and Technical Project Manager @thermofisher! His contribution concerning the role of deacetylated Sialic acids on BCRP (and related therapeutics) is revolutionary and will shape our approach to MDR for years to come. Thank you @ituffour1 !
3
2
1
14
455
It is always nice to come together for a celebration. I have deep admiration for you all. Thank you for the consistent dedication and effort in driving science. @rawc_lab
1
3
173
MIZ, a promising early stage therapeutic, reduces DNA damage, apoptosis and increases cell–matrix adhesion in CEES exposed skin cells. Check out this compelling work @ACSBioMed . pubs.acs.org/doi/10.1021/acs…
1
83